263 related articles for article (PubMed ID: 16899556)
1. Centrally administered neuropeptide W-30 activates magnocellular neurosecretory cells in the supraoptic and paraventricular nuclei with neurosecretion in rats.
Kawasaki M; Onaka T; Nakazato M; Saito J; Mera T; Hashimoto H; Fujihara H; Okimoto N; Ohnishi H; Nakamura T; Ueta Y
J Endocrinol; 2006 Aug; 190(2):213-23. PubMed ID: 16899556
[TBL] [Abstract][Full Text] [Related]
2. Effects of centrally administered pituitary adenylate cyclase-activating polypeptide on c-fos gene expression and heteronuclear RNA for vasopressin in rat paraventricular and supraoptic nuclei.
Nomura M; Ueta Y; Serino R; Yamamoto Y; Shibuya I; Yamashita H
Neuroendocrinology; 1999 Mar; 69(3):167-80. PubMed ID: 10087449
[TBL] [Abstract][Full Text] [Related]
3. Centrally administered adrenomedullin increases plasma oxytocin level with induction of c-fos messenger ribonucleic acid in the paraventricular and supraoptic nuclei of the rat.
Serino R; Ueta Y; Hara Y; Nomura M; Yamamoto Y; Shibuya I; Hattori Y; Kitamura K; Kangawa K; Russell JA; Yamashita H
Endocrinology; 1999 May; 140(5):2334-42. PubMed ID: 10218987
[TBL] [Abstract][Full Text] [Related]
4. Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat.
Larsen PJ; Tang-Christensen M; Jessop DS
Endocrinology; 1997 Oct; 138(10):4445-55. PubMed ID: 9322962
[TBL] [Abstract][Full Text] [Related]
5. Vasopressin- and oxytocin-immunoreactive nerve cells in the aging rat hypothalamus.
Lolova IS; Davidoff MS; Yakimoff NA
Acta Physiol Pharmacol Bulg; 1996; 22(1):7-16. PubMed ID: 8870838
[TBL] [Abstract][Full Text] [Related]
6. In situ hybridization analysis of vasopressin gene transcription in the paraventricular and supraoptic nuclei of the rat: regulation by stress and glucocorticoids.
Herman JP
J Comp Neurol; 1995 Dec; 363(1):15-27. PubMed ID: 8682934
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of magnocellular vasopressin mRNA in rats with deoxycorticosterone-acetate induced salt appetite.
Grillo CA; Saravia F; Ferrini M; Piroli G; Roig P; García SI; de Kloet ER; De Nicola AF
Neuroendocrinology; 1998 Aug; 68(2):105-15. PubMed ID: 9705577
[TBL] [Abstract][Full Text] [Related]
8. C-fos mRNA pattern and corticotropin-releasing factor neuronal activity throughout the brain of rats injected centrally with a prostaglandin of E2 type.
Lacroix S; Valliéres L; Rivest S
J Neuroimmunol; 1996 Nov; 70(2):163-79. PubMed ID: 8898725
[TBL] [Abstract][Full Text] [Related]
9. The effects of estrogen and progesterone on corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid levels in the paraventricular nucleus and supraoptic nucleus of the rhesus monkey.
Roy BN; Reid RL; Van Vugt DA
Endocrinology; 1999 May; 140(5):2191-8. PubMed ID: 10218971
[TBL] [Abstract][Full Text] [Related]
10. Role of arginine vasopressin and corticotropin-releasing factor in mediating alcohol-induced adrenocorticotropin and vasopressin secretion in male rats bearing lesions of the paraventricular nuclei.
Ogilvie KM; Lee S; Rivier C
Brain Res; 1997 Jan; 744(1):83-95. PubMed ID: 9030416
[TBL] [Abstract][Full Text] [Related]
11. Centrally administered parathyroid hormone (PTH)-related protein(1-34) but not PTH(1-34) stimulates arginine-vasopressin secretion and its messenger ribonucleic acid expression in supraoptic nucleus of the conscious rats.
Yamamoto S; Morimoto I; Zeki K; Ueta Y; Yamashita H; Kannan H; Eto S
Endocrinology; 1998 Jan; 139(1):383-8. PubMed ID: 9421437
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of the expression of vasopressin gene in the paraventricular and supraoptic nuclei of the lithium-induced diabetes insipidus rat.
Anai H; Ueta Y; Serino R; Nomura M; Kabashima N; Shibuya I; Takasugi M; Nakashima Y; Yamashita H
Brain Res; 1997 Oct; 772(1-2):161-6. PubMed ID: 9406968
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of hypothalamic nitric oxide synthase gene expression in streptozotocin-induced diabetic rats.
Serino R; Ueta Y; Tokunaga M; Hara Y; Nomura M; Kabashima N; Shibuya I; Hattori Y; Yamashita H
Diabetologia; 1998 Jun; 41(6):640-8. PubMed ID: 9662044
[TBL] [Abstract][Full Text] [Related]
14. Hypotension preferentially induces c-fos immunoreactivity in supraoptic vasopressin neurons.
Shen E; Dun SL; Ren C; Bennett-Clarke C; Dun NJ
Brain Res; 1992 Oct; 593(1):136-9. PubMed ID: 1458316
[TBL] [Abstract][Full Text] [Related]
15. Dehydration stimulates hypothalamic gene expression of histamine synthesis enzyme: importance for neuroendocrine regulation of vasopressin and oxytocin secretion.
Kjaer A; Larsen PJ; Knigge U; Warberg J
Endocrinology; 1995 May; 136(5):2189-97. PubMed ID: 7720668
[TBL] [Abstract][Full Text] [Related]
16. Electrical activation and c-fos mRNA expression in rat neurosecretory neurones after systemic administration of cholecystokinin.
Hamamura M; Leng G; Emson PC; Kiyama H
J Physiol; 1991 Dec; 444():51-63. PubMed ID: 1822561
[TBL] [Abstract][Full Text] [Related]
17. Histamine stimulates c-fos expression in hypothalamic vasopressin-, oxytocin-, and corticotropin-releasing hormone-containing neurons.
Kjaer A; Larsen PJ; Knigge U; Møller M; Warberg J
Endocrinology; 1994 Jan; 134(1):482-91. PubMed ID: 8275963
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II-induced vasopressin release is mediated through alpha-1 adrenoceptors and angiotensin II AT1 receptors in the supraoptic nucleus.
Qadri F; Culman J; Veltmar A; Maas K; Rascher W; Unger T
J Pharmacol Exp Ther; 1993 Nov; 267(2):567-74. PubMed ID: 8246129
[TBL] [Abstract][Full Text] [Related]
19. Short-term effects of centrally administered galanin on the hyperosmotically stimulated expression of vasopressin in the rat hypothalamus. An in situ hybridization and immunohistochemistry study.
Landry M; Roche D; Calas A
Neuroendocrinology; 1995 Apr; 61(4):393-404. PubMed ID: 7540263
[TBL] [Abstract][Full Text] [Related]
20. The magnocellular arginine-vasopressin mRNA responds differently to food deprivation between the supraoptic and paraventricular nuclei of the hypothalamus in adrenalectomized rats with low corticosterone replacement.
Ogasa T; Hashimoto K; Suemaru S; Kageyama J; Ota Z
Brain Res; 1992 Jun; 583(1-2):45-53. PubMed ID: 1504843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
